Virtuix sold and shipped two Omni One immersive VR systems to Sirica Therapeutics’ first San Francisco Bay Area autism treatment center under their new strategic partnership. Sirica plans to establish about 100 centers nationwide using AI-assisted, movement-centered virtual reality to enhance therapy outcomes for children with autism.
Virtuix announced a strategic partnership with Sirica Therapeutics to deploy its Omni One platform in autism therapy applications, marking its entry into clinical healthcare markets.
As part of the deal, Virtuix sold and shipped the first two Omni One immersive VR systems to Sirica’s inaugural treatment center in the San Francisco Bay Area.
Sirica intends to establish approximately 100 specialized autism treatment centers across the U.S., leveraging Omni One to enhance engagement and outcomes through AI-assisted, movement-centered therapy.
The collaboration builds on Virtuix’s broader healthcare strategy following research initiatives at Rutgers and Florida Gulf Coast University, positioning the company for growth in clinical XR applications.
